• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
An Azidoribose Probe to Track Ketoamine Adducts in Histone Ribose Glycation.一种用于追踪组蛋白核糖基糖化中酮胺加合物的 Azidoribose 探针。
J Am Chem Soc. 2020 Jun 3;142(22):9999-10007. doi: 10.1021/jacs.0c01325. Epub 2020 May 22.
2
Chemical Labeling and Enrichment of Histone Glyoxal Adducts.化学标记和组蛋白糖醛酸加合物的富集。
ACS Chem Biol. 2022 Apr 15;17(4):756-761. doi: 10.1021/acschembio.1c00864. Epub 2022 Mar 16.
3
Intrinsic toxicity of glucose, due to non-enzymatic glycation, is controlled in-vivo by deglycation systems including: FN3K-mediated deglycation of fructosamines and transglycation of aldosamines.由于非酶糖基化作用,葡萄糖的内在毒性在体内由包括以下的去糖基化系统控制:FN3K介导的果糖胺去糖基化作用和醛糖胺的转糖基化作用。
Med Hypotheses. 2005;65(2):337-48. doi: 10.1016/j.mehy.2005.02.017.
4
Synthesis of an Alkynyl Methylglyoxal Probe to Investigate Nonenzymatic Histone Glycation.用于研究非酶促组蛋白糖基化的炔基甲基乙二醛探针的合成
J Org Chem. 2020 Feb 7;85(3):1691-1697. doi: 10.1021/acs.joc.9b02504. Epub 2020 Jan 7.
5
ADP-ribose in glycation and glycoxidation reactions.糖基化和糖氧化反应中的ADP - 核糖
Adv Exp Med Biol. 1997;419:371-9. doi: 10.1007/978-1-4419-8632-0_49.
6
Rutin metabolites: novel inhibitors of nonoxidative advanced glycation end products.芦丁代谢物:新型非氧化型晚期糖基化终产物抑制剂。
Free Radic Biol Med. 2010 Mar 1;48(5):656-63. doi: 10.1016/j.freeradbiomed.2009.11.019. Epub 2009 Dec 4.
7
Nonenzymatic glycation of histones in vitro and in vivo.组蛋白在体外和体内的非酶糖基化作用。
J Cell Biochem. 2002;85(1):24-34.
8
A Hypothesis: Fructosamine-3-Kinase-Related-Protein (FN3KRP) Catalyzes Deglycation of Maillard Intermediates Directly Downstream from Fructosamines.一种假说:果糖胺-3-激酶相关蛋白(FN3KRP)催化果糖胺下游直接的美拉德中间体的去糖基化反应。
Rejuvenation Res. 2021 Aug;24(4):310-318. doi: 10.1089/rej.2021.0009.
9
Glycation and glycoxidation of histones by ADP-ribose.组蛋白被 ADP - 核糖进行糖基化和糖氧化反应。
J Biol Chem. 1996 May 3;271(18):10461-9. doi: 10.1074/jbc.271.18.10461.
10
Nonenzymatic glycosylation of isolated human immunoglobulin-G by D-ribose.D-核糖对人免疫球蛋白-G 的非酶糖化作用。
Cell Biochem Funct. 2022 Jul;40(5):526-534. doi: 10.1002/cbf.3722. Epub 2022 Jun 16.

引用本文的文献

1
Structural basis for FN3K-mediated protein deglycation.FN3K 介导的蛋白质去糖基化的结构基础。
Structure. 2024 Oct 3;32(10):1711-1724.e5. doi: 10.1016/j.str.2024.07.018. Epub 2024 Aug 21.
2
The chemical language of protein glycation.蛋白质糖基化的化学语言。
Nat Chem Biol. 2025 Mar;21(3):324-336. doi: 10.1038/s41589-024-01644-y. Epub 2024 Jun 28.
3
Epigenetic meets metabolism: novel vulnerabilities to fight cancer.表观遗传学与代谢:攻克癌症的新靶点。
Cell Commun Signal. 2023 Sep 21;21(1):249. doi: 10.1186/s12964-023-01253-7.
4
A global view of the human post-translational modification landscape.人类翻译后修饰全景图。
Biochem J. 2023 Aug 30;480(16):1241-1265. doi: 10.1042/BCJ20220251.
5
Reconsidering the role of protein glycation in disease.重新审视蛋白质糖基化在疾病中的作用。
Nat Chem Biol. 2023 Aug;19(8):922-927. doi: 10.1038/s41589-023-01382-7.
6
Leveraging histone glycation for cancer diagnostics and therapeutics.利用组蛋白糖化进行癌症诊断和治疗。
Trends Cancer. 2023 May;9(5):410-420. doi: 10.1016/j.trecan.2023.01.005. Epub 2023 Feb 18.
7
Chromatin structure in cancer.染色质结构与癌症。
BMC Mol Cell Biol. 2022 Jul 28;23(1):35. doi: 10.1186/s12860-022-00433-6.
8
Chemical Labeling and Enrichment of Histone Glyoxal Adducts.化学标记和组蛋白糖醛酸加合物的富集。
ACS Chem Biol. 2022 Apr 15;17(4):756-761. doi: 10.1021/acschembio.1c00864. Epub 2022 Mar 16.
9
Anomeric Fatty Acid Functionalization Prevents Nonenzymatic -Glycosylation by Monosaccharide Metabolic Chemical Reporters.糖基化非酶促反应的单糖代谢化学报告物的糖端脂肪酸功能化修饰
ACS Chem Biol. 2021 Oct 15;16(10):1924-1929. doi: 10.1021/acschembio.1c00470. Epub 2021 Jul 20.
10
A chemical field guide to histone nonenzymatic modifications.组蛋白非酶修饰的化学野外指南。
Curr Opin Chem Biol. 2021 Aug;63:180-187. doi: 10.1016/j.cbpa.2021.05.002. Epub 2021 Jun 20.

本文引用的文献

1
Protein arginine deiminase 4 antagonizes methylglyoxal-induced histone glycation.蛋白精氨酸脱亚氨酶 4 拮抗甲基乙二醛诱导的组蛋白糖基化。
Nat Commun. 2020 Jun 26;11(1):3241. doi: 10.1038/s41467-020-17066-y.
2
Synthesis of an Alkynyl Methylglyoxal Probe to Investigate Nonenzymatic Histone Glycation.用于研究非酶促组蛋白糖基化的炔基甲基乙二醛探针的合成
J Org Chem. 2020 Feb 7;85(3):1691-1697. doi: 10.1021/acs.joc.9b02504. Epub 2020 Jan 7.
3
The Oncogenic Action of NRF2 Depends on De-glycation by Fructosamine-3-Kinase.NRF2 的致癌作用取决于果糖胺-3-激酶的去糖基化作用。
Cell. 2019 Aug 8;178(4):807-819.e21. doi: 10.1016/j.cell.2019.07.031.
4
Calcium Regulates the Nuclear Localization of Protein Arginine Deiminase 2.钙调节蛋白精氨酸脱亚氨酶 2 的核定位。
Biochemistry. 2019 Jul 9;58(27):3042-3056. doi: 10.1021/acs.biochem.9b00225. Epub 2019 Jun 27.
5
Reversible histone glycation is associated with disease-related changes in chromatin architecture.可逆的组蛋白糖化与染色质结构的疾病相关变化有关。
Nat Commun. 2019 Mar 20;10(1):1289. doi: 10.1038/s41467-019-09192-z.
6
Insights into the Chemistry of Non-Enzymatic Browning Reactions in Different Ribose-Amino Acid Model Systems.不同核糖-氨基酸模型体系中非酶褐变反应的化学研究进展。
Sci Rep. 2018 Nov 15;8(1):16879. doi: 10.1038/s41598-018-34335-5.
7
The PRIDE database and related tools and resources in 2019: improving support for quantification data.PRIDE 数据库及相关工具和资源在 2019 年的进展:提高定量数据支持。
Nucleic Acids Res. 2019 Jan 8;47(D1):D442-D450. doi: 10.1093/nar/gky1106.
8
A metabolite-derived protein modification integrates glycolysis with KEAP1-NRF2 signalling.代谢物衍生的蛋白质修饰将糖酵解与 KEAP1-NRF2 信号通路整合在一起。
Nature. 2018 Oct;562(7728):600-604. doi: 10.1038/s41586-018-0622-0. Epub 2018 Oct 15.
9
Methylglyoxal-derived posttranslational arginine modifications are abundant histone marks.甲基乙二醛衍生的翻译后精氨酸修饰是丰富的组蛋白标记。
Proc Natl Acad Sci U S A. 2018 Sep 11;115(37):9228-9233. doi: 10.1073/pnas.1802901115. Epub 2018 Aug 27.
10
Metabolic regulation of chromatin modifications and gene expression.染色质修饰和基因表达的代谢调控。
J Cell Biol. 2018 Jul 2;217(7):2247-2259. doi: 10.1083/jcb.201803061. Epub 2018 May 14.

一种用于追踪组蛋白核糖基糖化中酮胺加合物的 Azidoribose 探针。

An Azidoribose Probe to Track Ketoamine Adducts in Histone Ribose Glycation.

机构信息

Tri-Institutional PhD Program in Chemical Biology, New York, New York 10065, United States.

Chemical Biology Program, Memorial Sloan Kettering Cancer Center, New York, New York 10065, United States.

出版信息

J Am Chem Soc. 2020 Jun 3;142(22):9999-10007. doi: 10.1021/jacs.0c01325. Epub 2020 May 22.

DOI:10.1021/jacs.0c01325
PMID:32390412
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8052992/
Abstract

Reactive cellular metabolites can modify macromolecules and form adducts known as nonenzymatic covalent modifications (NECMs). The dissection of the mechanisms, regulation, and consequences of NECMs, such as glycation, has been challenging due to the complex and often ambiguous nature of the adducts formed. Specific chemical tools are required to directly track the formation of these modifications on key targets in order to uncover their underlying physiological importance. Here, we present the novel chemoenzymatic synthesis of an active azido-modified ribose analog, 5-azidoribose (), as well as the synthesis of an inactive control derivative, 1-azidoribose (), and their application toward understanding protein ribose-glycation and . With these new probes we found that, similar to methylglyoxal (MGO) glycation, ribose glycation specifically accumulates on histones. In addition to fluorescent labeling, we demonstrate the utility of the probe in enriching modified targets, which were identified by label-free quantitative proteomics and high-resolution MS/MS workflows. Finally, we establish that the known oncoprotein and hexose deglycase, fructosamine 3-kinase (FN3K), recognizes and facilitates the removal of glycation adducts in live cells, supporting the dynamic regulation of ribose glycation as well as validating the probe as a new platform to monitor FN3K activity. Altogether, we demonstrate this probe's utilities to uncover ribose-glycation and deglycation events as well as track FN3K activity toward establishing its potential as a new cancer vulnerability.

摘要

反应性细胞代谢物可以修饰大分子并形成加合物,称为非酶共价修饰 (NECM)。由于形成的加合物复杂且通常不明确,因此对 NECM 的机制、调节和后果(如糖化)的剖析具有挑战性。需要特定的化学工具来直接追踪这些修饰在关键靶标上的形成,以揭示它们潜在的生理重要性。在这里,我们提出了一种新型的化学酶合成活性叠氮修饰核糖类似物 5-叠氮核糖 (5-Azido-ribose ()) 的方法,以及一种非活性对照衍生物 1-叠氮核糖 (1-Azido-ribose ()) 的合成方法,并将其应用于理解蛋白质核糖糖化和去糖化。使用这些新探针,我们发现与甲基乙二醛 (MGO) 糖化类似,核糖糖化会特异性地在组蛋白上积累。除了荧光标记外,我们还证明了探针在富集修饰靶标方面的实用性,这些靶标是通过无标记定量蛋白质组学和高分辨率 MS/MS 工作流程鉴定的。最后,我们确定了已知的癌蛋白和己糖去糖基酶果糖胺 3-激酶 (FN3K) 识别并促进活细胞中 糖化加合物的去除,这支持了核糖糖化的动态调节,并验证了探针作为监测 FN3K 活性的新平台的潜力。总之,我们展示了该探针在揭示核糖糖化和去糖化事件以及追踪 FN3K 活性方面的实用性,为确定其作为新的癌症脆弱性的潜力奠定了基础。